Literature DB >> 12547703

Role for the alternative complement pathway in ischemia/reperfusion injury.

Gregory L Stahl1, Yuanyuan Xu, Liming Hao, Mendy Miller, Jon A Buras, Michael Fung, Hui Zhao.   

Abstract

The terminal complement components play an important role in mediating tissue injury after ischemia and reperfusion (I/R) injury in rats and mice. However, the specific complement pathways involved in I/R injury are unknown. The role of the alternative pathway in I/R injury may be particularly important, as it amplifies complement activation and deposition. In this study, the role of the alternative pathway in I/R injury was evaluated using factor D-deficient (-/-) and heterozygote (+/-) mice. Gastrointestinal ischemia (GI) was induced by clamping the mesenteric artery for 20 minutes and then reperfused for 3 hours. Sham-operated control mice (+/- versus -/-) had similar baseline intestinal lactate dehydrogenase activity (P = ns). Intestinal lactate dehydrogenase activity was greater in -/- mice compared to +/- mice after GI/R (P = 0.02) thus demonstrating protection in the -/- mice. Intestinal myeloperoxidase activity in +/- mice was significantly greater than -/- mice after GI/R (P < 0.001). Pulmonary myeloperoxidase activity after GI/R was significantly higher in +/- than -/- mice (P = 0.03). Addition of human factor D to -/- animals restored GI/R injury and was prevented by a functionally inhibitory antibody against human factor D. These data suggest that the alternative complement pathway plays an important role in local and remote tissue injury after GI/R. Inhibition of factor D may represent an effective therapeutic approach for GI/R injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12547703      PMCID: PMC1851150          DOI: 10.1016/S0002-9440(10)63839-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  Isolation of complement protein D from urine of patients with Fanconi's syndrome.

Authors:  J E Volanakis; K J Macon
Journal:  Anal Biochem       Date:  1987-05-15       Impact factor: 3.365

2.  Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine.

Authors:  Thiruma V Arumugam; Ian A Shiels; Trent M Woodruff; Robert C Reid; David P Fairlie; Stephen M Taylor
Journal:  J Surg Res       Date:  2002-04       Impact factor: 2.192

3.  How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease.

Authors:  Isao Matsumoto; Mariana Maccioni; David M Lee; Madelon Maurice; Barry Simmons; Michael Brenner; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2002-03-18       Impact factor: 25.606

4.  Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion.

Authors:  M Buerke; T Murohara; A M Lefer
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

5.  Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.

Authors:  E A Amsterdam; G L Stahl; H L Pan; S V Rendig; M P Fletcher; J C Longhurst
Journal:  Am J Physiol       Date:  1995-01

6.  Mutational analysis of the substrate binding site of human complement factor D.

Authors:  S Kim; S V Narayana; J E Volanakis
Journal:  Biochemistry       Date:  1994-12-06       Impact factor: 3.162

7.  Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis.

Authors:  Kazue Takahashi; Judith Gordon; Hong Liu; Kedarnath N Sastry; Judy E Epstein; Monica Motwani; Inga Laursen; Steffen Thiel; Jens Christain Jensenius; Michael Carroll; R Alan B Ezekowitz
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

8.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.

Authors:  H F Weisman; T Bartow; M K Leppo; H C Marsh; G R Carson; M F Concino; M P Boyle; K H Roux; M L Weisfeldt; D T Fearon
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

9.  Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.

Authors:  D T Fearon; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

10.  Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.

Authors:  M R Weiser; J P Williams; F D Moore; L Kobzik; M Ma; H B Hechtman; M C Carroll
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  62 in total

Review 1.  Complement in ischemia reperfusion injury.

Authors:  Niels C Riedemann; Peter A Ward
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

2.  The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation.

Authors:  M Harboe; G Ulvund; L Vien; M Fung; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

Review 3.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

Review 4.  Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation.

Authors:  Hans U Lutz; Peter J Späth
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 5.  The role of complement in the antiphospholipid syndrome-associated pathology.

Authors:  Ingrid Avalos; George C Tsokos
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

6.  The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy.

Authors:  K Csencsits; B E Burrell; G Lu; E J Eichwald; G L Stahl; D K Bishop
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

7.  Distinct different contributions of the alternative and classical complement activation pathway for the innate host response during sepsis.

Authors:  Katja Dahlke; Christiane D Wrann; Oliver Sommerfeld; Maik Sossdorf; Peter Recknagel; Svea Sachse; Sebastian W Winter; Andreas Klos; Gregory L Stahl; Yuanyuan Xu Ma; Ralf A Claus; Konrad Reinhart; Michael Bauer; Niels C Riedemann
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

8.  Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis.

Authors:  Vasile I Pavlov; Mikkel-Ole Skjoedt; Ying Siow Tan; Anne Rosbjerg; Peter Garred; Gregory L Stahl
Journal:  Circulation       Date:  2012-10-02       Impact factor: 29.690

Review 9.  Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury.

Authors:  Emily Archer Slone; Sherry D Fleming
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

10.  Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury.

Authors:  Haekyung Lee; Danielle J Green; Lawrence Lai; Yunfang Joan Hou; Jens C Jensenius; David Liu; Cheolho Cheong; Chae Gyu Park; Ming Zhang
Journal:  Mol Immunol       Date:  2009-12-09       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.